Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment
Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment
复制标题
DOI:
10.1016/j.neurobiolaging.2009.01.013
复制
发表时间:
2011-01-01
影响因子:
4.2
通讯作者:
Dubois, Bruno
中科院分区:
文献类型:
--
作者:
Habert, Marie-Odile;Horn, Jean-Francois;Dubois, Bruno
Objective: To improve diagnosis of early Alzheimer's disease (AD), i.e., prodromal AD, by an automated quantitative tool combining brain perfusion single-photon emission computed tomography (SPECT) images and memory tests scores in order to be applied in clinical practice.Patients and methods: In this prospective, longitudinal, multi-centric study, a baseline Tc-99m-ECD perfusion SPECT was performed in 83 patients with memory complaint and mild cognitive impairment (MCI). After a 3-year follow-up, 11 patients progressed to Alzheimer's disease (MCI-AD group), and 72 patients remained stable (MCI-S group), including 1 patient who developed mild vascular cognitive impairment. After comparison between the MCI-S and MCI-AD groups with a voxel-based approach, region masks were extracted from the statistically significant clusters and used alone or in combination with Free and Cued Selective Reminding Test (FCSRT) scores for the subject's categorization using linear discriminant analysis.Results were validated using the leave-one-out cross-validation method. Results: Right parietal and hippocampal perfusion was significantly (p